Yinghua Li

Dr. Yinghua Li

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2023 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
KXKe Xu
Ke Xu
WFWenchao Fei
Wenchao Fei
WGWenxue Gao
Wenxue Gao
CFChangxiu Fan
Changxiu Fan
YLYinghua Li
Yinghua Li
RCRan Cui
Ran Cui
Osteoporosis is a chronic disease that seriously affects the quality of life and longevity of the elderly, so exploring the mechanism of osteoporosis is crucial for drug development and treatment. Bone marrow mesenchymal stem cells are stem cells with multiple differentiation potentials in bone marrow, and changing their differentiation direction can change bone mass. As an extracellular superoxide dismutase, Superoxide Dismutase 3 (SOD3) has been proved to play an important role in multiple organs, but the detailed mechanism of action in bone metabolism is still unclear. In this study, the results of clinical serum samples ELISA and single cell sequencing chip analysis proved that the expression of SOD3 was positively correlated with bone mass, and SOD3 was mainly expressed in osteoblasts and adipocytes and rarely expressed in osteoblasts in BMSCs. In vitro experiments showed that SOD3 can promote osteogenesis and inhibit adipogenesis. Compared with WT mice, the mice that were knocked out of SOD3 had a significant decrease in bone mineral density and significant changes in related parameters. The results of HE and IHC staining suggested that knocking out SOD3 would lead to fat accumulation in the bone marrow cavity and weakened osteogenesis. Both in vitro and in vivo experiments indicated that SOD3 affects bone metabolism by promoting osteogenesis and inhibiting adipogenesis. The results of transcriptome sequencing and revalidation showed that SOD3 can affect the expression of FLT1. Through in vitro experiments, we proved that FLT1 can also promote osteogenesis and inhibit adipogenesis. In addition, through the repeated experiments, the interaction between the two molecules (SOD3 and FLT1) was verified again. Finally, it was verified by WB that SOD3 regulates FLT1 to affect bone metabolism through PI3K/AKT and MAPK pathways.

13 October 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
JYJiali Yang
Jiali Yang
QFQiqi Fu
Qiqi Fu
HJHui Jiang
Hui Jiang
YLYinghua Li
Yinghua Li
MLMuqing Liu
Muqing Liu
Osteosarcoma (OS) is the most common primary malignant bone tumor that mainly affects the pediatric and adolescent population; limb salvage treatment has become one of the most concerned and expected outcomes of OS patients recently. Phototherapy (PT), as a novel, non-invasive, and efficient antitumor therapeutic approach including photodynamic therapy (PDT), photothermal therapy (PTT), and photobiomodulation therapy (PBMT), has been widely applied in superficial skin tumor research and clinical treatment. OS is the typical deep tumor, and its phototherapy research faces great limitations and challenges. Surprisingly, pulse mode LED light can effectively improve tissue penetration and reduce skin damage caused by high light intensity and has great application potential in deep tumor research. In this review, we discussed the research progress and related molecular mechanisms of phototherapy in the treatment of OS, mainly summarized the status quo of blue light PBMT in the scientific research and clinical applications of tumor treatment, and outlooked the application prospect of pulsed blue LED light in the treatment of OS, so as to further improve clinical survival rate and prognosis of OS treatment and explore corresponding cellular mechanisms.

15 February 2023 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
ZCZeqing Chen
Zeqing Chen
RZRuixiao Zhang
Ruixiao Zhang
HQHaokuan Qin
Haokuan Qin
HJHui Jiang
Hui Jiang
AWAixia Wang
Aixia Wang
MLMuqing Liu
Muqing Liu

30 October 2021 in Archives of Osteoporosis
Verified
Journal Article
Closed access
PDF file
RCRan Cui
Ran Cui
ZZZheng Zhao
Zheng Zhao
ZFZhaoliang Fei
Zhaoliang Fei
YLYinghua Li
Yinghua Li
WGWenxue Gao
Wenxue Gao

31 January 2024 in Photonics
Verified
Journal Article
Open access
PDF file
QFQiqi Fu
Qiqi Fu
HJHui Jiang
Hui Jiang
JYJiali Yang
Jiali Yang
YLYafei Li
Yafei Li
HFHe Fei
He Fei
MLMuqing Liu
Muqing Liu
In recent years, photobiomodulation (PBM) has attracted widespread attention for the treatment of various causes of pain and inflammation. Primary dysmenorrhea (PD) is a common gynecological condition characterized by severe menstrual pain, and the limited effectiveness and side effects of conventional treatments have highlighted the urgent need to develop and identify new adjunct therapeutic strategies. The present study from the perspective of light morphology aimed to bypass the heat risk limitation and evaluate the efficacy and safety of pulsed 630 nm PBM therapy for reducing pain associated with PD. The pulse light parameters were designed according to the transmittance of red light. In this randomized, cross-over design, sham-controlled study, 46 women with PD were included and randomly assigned to either pulsed 630 nm light therapy or white light sham control therapy. The intervention lasted for 20 min per day and was administered for 7 consecutive days before and during menstruation. The results showed that the pulsed 630 nm PBM treatment demonstrated a significant reduction in pain levels compared to the placebo treatment (p < 0.001), with 55.00% of active treatment participants experiencing a pain intensity differential concentration exceeding 50.00%. Moreover, participants reported an improved quality of life during the active treatment phase and generally preferred it as a more effective method for relieving PD. No adverse events or side effects were reported throughout the trial. Based on the results, pulsed 630 nm LED therapy showed significant relief of menstrual pain compared to white light placebo treatment and improved quality of life under certain circumstances. Therefore, this study proposes that pulsed red light PBM therapy may be a promising approach for future clinical treatment of PD.

3 August 2024 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
JYJiali Yang
Jiali Yang
QFQiqi Fu
Qiqi Fu
HJHui Jiang
Hui Jiang
HZHongyu Zhong
Hongyu Zhong
HQHao Kuan Qin
Hao Kuan Qin
YJyao jinghui
yao jinghui